{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:18:07Z","timestamp":1774959487051,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/igc.0000000000000037","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T04:07:10Z","timestamp":1389154030000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Growth Differentiation Factor-15 as Biomarker in Uterine Sarcomas"],"prefix":"10.1016","volume":"24","author":[{"given":"Jone","family":"Trovik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga Birgitte","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine","family":"Cuppens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Amant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Cathrine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0000000000000037_bb0005","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0010","first-page":"414","article-title":"Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma","volume":"83","author":"Parker","year":"1994","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000037_bb0015","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/cncr.10382","article-title":"Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma","volume":"94","author":"Kawamura","year":"2002","journal-title":"Cancer."},{"issue":"discussion 74-6","key":"10.1097\/IGC.0000000000000037_bb0020","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000037_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","article-title":"The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma","volume":"122","author":"Park","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","article-title":"Uterine leiomyosarcoma: does the primary surgical procedure matter","volume":"19","author":"Perri","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0000000000000037_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bpobgyn.2011.08.002","article-title":"Screening for uterine tumours","volume":"26","author":"Van den Bosch","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1097\/IGC.0000000000000037_bb0040","first-page":"412","article-title":"Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population","volume":"30","author":"Yilmaz","year":"2009","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0045","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0000000000000037_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","article-title":"Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer","volume":"118","author":"Staff AC","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0055","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-11-0715","article-title":"Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer","volume":"17","author":"Staff AC","year":"2011","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0000000000000037_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0000000000000037_bb0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.10.792","article-title":"Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary","volume":"198","author":"Odegaard","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0000000000000037_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","article-title":"Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay","volume":"53","author":"Kempf","year":"2007","journal-title":"Clin Chem."},{"key":"10.1097\/IGC.0000000000000037_bb0075","article-title":"Endometrial Carcinoma; Can Biomarkers Aid in the Prediction of Aggressive Disease?","author":"Trovik","year":"2012","journal-title":"Bergen, Norway: University of Bergen, Norway"},{"key":"10.1097\/IGC.0000000000000037_bb0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell."},{"key":"10.1097\/IGC.0000000000000037_bb0085","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","article-title":"Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study","volume":"359","author":"Brown","year":"2002","journal-title":"Lancet."},{"key":"10.1097\/IGC.0000000000000037_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene."},{"key":"10.1097\/IGC.0000000000000037_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/HYPERTENSIONAHA.109.130583","article-title":"Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus","volume":"54","author":"Sugulle","year":"2009","journal-title":"Hypertension."},{"key":"10.1097\/IGC.0000000000000037_bb0100","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1097\/IGC.0000000000000037_bb0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"10.1097\/IGC.0000000000000037_bb0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejso.2010.05.004","article-title":"Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison","volume":"36","author":"Kim","year":"2010","journal-title":"Eur J Surg Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0115","first-page":"543","article-title":"Growth differentiation factor-15\/macrophage inhibitory cytokine-1 induction after kidney and lung injury","volume":"23","author":"Zimmers","year":"2005","journal-title":"Shock."},{"key":"10.1097\/IGC.0000000000000037_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1078-0432.CCR-05-1331","article-title":"Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis","volume":"12","author":"Brown","year":"2006","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0000000000000037_bb0125","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","article-title":"Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers","volume":"10","author":"Koopmann","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0000000000000037_bb0130","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1073\/pnas.0607210103","article-title":"Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors","volume":"103","author":"Agarwal","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1097\/IGC.0000000000000037_bb0135","first-page":"370","article-title":"Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma","volume":"27","author":"Juang","year":"2006","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1097\/IGC.0000000000000037_bb0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ijgc-00009577-200207000-00005","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0000000000000037_bb0145","first-page":"1069","article-title":"Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas","volume":"23","author":"Nagamatsu","year":"2010","journal-title":"Oncol Rep."},{"key":"10.1097\/IGC.0000000000000037_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24022527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24022527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0000000000000037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:29:34Z","timestamp":1753223374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24022527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1048891X24022527"],"URL":"https:\/\/doi.org\/10.1097\/igc.0000000000000037","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth Differentiation Factor-15 as Biomarker in Uterine Sarcomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0000000000000037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.","name":"copyright","label":"Copyright"}]}}